William Blair, Mersana Therapeutics
Analysts at William Blair raised their Q1 2025 EPS estimates for Kforce in a research report issued to clients and investors on Tuesday, February 4th. William Blair analyst T. Romeo now anticipates ...
1d
Hosted on MSNWilliam Blair Upgrades Tempur Sealy International (TPX)Fintel reports that on February 5, 2025, William Blair upgraded their outlook for Tempur Sealy International (NYSE:TPX) from ...
William Blair initiated coverage of Mersana Therapeutics (MRSN) with an Outperform rating.Maximize Your Portfolio with Data Driven ...
Equities research analysts at William Blair lowered their Q1 2025 earnings estimates for STMicroelectronics in a report issued on Monday, February 3rd. William Blair analyst J. Dorsheimer now expects ...
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
CHICAGO (WLS) -- Portillo's beat McDonald's for best value in fast food, according to a new consumer survey from William ...
Karman Holdings, backed by Trive Capital, said on Wednesday that it is targeting a valuation of up to $2.6 billion in its New ...
William Blair International Growth Fund earns an Average Process Pillar rating. The main driver of the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ...
In a report released today, Arjun Bhatia from William Blair maintained a Buy rating on Braze (BRZE – Research Report). The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results